Becker JC - Search Results

1

Immunogenicity of constitutively active V599EBRaf.

Andersen MH, Fensterle J, Ugurel S, Reker S, Houben R, Guldberg P, Berger TG, Schadendorf D, Trefzer U, Bröcker EB, Straten Pt, Rapp UR, Becker JC. Andersen MH, et al. Among authors: becker jc. Cancer Res. 2004 Aug 1;64(15):5456-60. doi: 10.1158/0008-5472.CAN-04-0937. Cancer Res. 2004. PMID: 15289355

2

[Cell therapy with dendritic cells].

Kämpgen E, Becker J, Bröcker EB. Kämpgen E, et al. Internist (Berl). 2001 Oct;42(10):1314-20. doi: 10.1007/s001080170053. Internist (Berl). 2001. PMID: 11688150 Review. German. No abstract available.

3

Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case report.

Pedersen LØ, Vetter CS, Mingari MC, Andersen MH, thor Straten P, Bröcker EB, Becker JC. Pedersen LØ, et al. Among authors: becker jc. J Invest Dermatol. 2002 Apr;118(4):595-9. doi: 10.1046/j.1523-1747.2002.01698.x. J Invest Dermatol. 2002. PMID: 11918704 Free article.

4

Expression of stress-induced MHC class I related chain molecules on human melanoma.

Vetter CS, Groh V, thor Straten P, Spies T, Bröcker EB, Becker JC. Vetter CS, et al. Among authors: becker jc. J Invest Dermatol. 2002 Apr;118(4):600-5. doi: 10.1046/j.1523-1747.2002.01700.x. J Invest Dermatol. 2002. PMID: 11918705 Free article.

5

Cytokine fusion protein treatment.

Schrama D, Straten Pt, Bröcker EB, Reisfeld RA, Becker JC. Schrama D, et al. Among authors: becker jc. Recent Results Cancer Res. 2002;160:185-94. doi: 10.1007/978-3-642-59410-6_22. Recent Results Cancer Res. 2002. PMID: 12079213

6

Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.

Wack C, Kirst A, Becker JC, Lutz WK, Bröcker EB, Fischer WH. Wack C, et al. Among authors: becker jc. Cancer Immunol Immunother. 2002 Oct;51(8):431-9. doi: 10.1007/s00262-002-0292-4. Epub 2002 Jul 25. Cancer Immunol Immunother. 2002. PMID: 12202904 Free PMC article.

7

Aggregation of antigen-specific T cells at the inoculation site of mature dendritic cells.

Schrama D, Pedersen LØ, Keikavoussi P, Andersen MH, Straten Pt Pt, Bröcker EB, Kämpgen E, Becker JC. Schrama D, et al. Among authors: becker jc. J Invest Dermatol. 2002 Dec;119(6):1443-8. doi: 10.1046/j.1523-1747.2002.19604.x. J Invest Dermatol. 2002. PMID: 12485452 Free article.

8

Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.

Hofmann UB, Eggert AA, Blass K, Bröcker EB, Becker JC. Hofmann UB, et al. Among authors: becker jc. Cancer Res. 2003 Dec 1;63(23):8221-5. Cancer Res. 2003. PMID: 14678978

9

HLA-B35-restricted immune responses against survivin in cancer patients.

Reker S, Becker JC, Svane IM, Ralfkiaer E, Straten PT, Andersen MH. Reker S, et al. Among authors: becker jc. Int J Cancer. 2004 Mar 1;108(6):937-41. doi: 10.1002/ijc.11634. Int J Cancer. 2004. PMID: 14712500

10

Hypopigmentary skin disorders: current treatment options and future directions.

Hartmann A, Bröcker EB, Becker JC. Hartmann A, et al. Among authors: becker jc. Drugs. 2004;64(1):89-107. doi: 10.2165/00003495-200464010-00006. Drugs. 2004. PMID: 14723560 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

660 results

Search Page

Filters